Table 2.

Descriptive statistics of the FEES-L-dopa-score and its subdomains, white-out duration, levodopa equivalent daily dose (LEDD), Hoehn and Yahr scale, and functional oral intake scale (FOIS), as well as the p value of the comparison before and after beginning of levodopa-carbidopa intestinal gel (LCIG) in the total cohort and the subgroup of patients with follow-up FEES before and after beginning with LCIG.

	Before LCIG	After LCIG	p value
Mean FEES-L-dopa-score ± SD
Subgroup	14.9 ± 7.3	13.0 ± 6.9	0.312
Mean score premature spillage ± SD
Subgroup	5.4 ± 1.1	3.6 ± 1.0	∗ 0.002
Mean score penetration/aspiration ± SD
Subgroup	0.3 ± 0.9	0.5 ± 1.0	0.690
Mean score residue ± SD
Subgroup	9.3 ± 5.9	8.9 ± 6.0	0.795
Mean white-out duration in ms ± SD
Subgroup	984 ± 228	699 ± 131	∗ 0.002
Mean Hoehn and Yahr ± SD
Total cohort	3.8 ± 0.7	3.5 ± 0.7	0.078
Subgroup	3.6 ± 0.5	3.8 ± 0.6	0.317
Mean LEDD ± SD
Total cohort	1182.9 ± 339.3	1684.2 ± 468.2	∗ <0.001
Subgroup	1246.1 ± 371.9	2062.0 ± 379.2	∗ <0.001
Mean FOIS ± SD
Total cohort	6.6 ± 1.1	6.6 ± 1.1	0.832
Subgroup	6.4 ± 0.9	6.6 ± 0.5	0.414